RAPT Therapeutics Inc. (RAPT)
NASDAQ: RAPT
· Real-Time Price · USD
12.73
1.43 (12.65%)
At close: Sep 04, 2025, 3:59 PM
12.73
0.00%
After-hours: Sep 04, 2025, 06:48 PM EDT
12.65% (1D)
| Bid | 11.43 |
| Market Cap | 210.53M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -106.49M |
| EPS (ttm) | -14.8 |
| PE Ratio (ttm) | -0.86 |
| Forward PE | -3.79 |
| Analyst | Hold |
| Ask | 13.25 |
| Volume | 96,769 |
| Avg. Volume (20D) | 104,443 |
| Open | 11.58 |
| Previous Close | 11.30 |
| Day's Range | 11.30 - 12.73 |
| 52-Week Range | 5.66 - 26.56 |
| Beta | 0.01 |
About RAPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RAPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RAPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+110.91%
RAPT Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
9 months ago
-39.45%
RAPT Therapeutics shares are trading lower after the company terminated its Zelnecirnon program following an FDA clinical hold due to a severe adverse event involving liver injury.
